Evidence map›Paper›PMID 39239330›Full record

ArticleJACC. CardioOncology2024

Circulating Macrotroponin Complexes and Their Impact on Cardiac Troponin Measurements: Potential Implications for Cardio-Oncology.

Inbar Nardi-Agmon, Ashley Di Meo, Leo Lam, Campbell Kyle, Husam Abdel-Qadir, Eitan Amir, Paaladinesh Thavendiranathan

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. CardioOncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Role of Troponins in CardioOncology.Current treatment options in oncology · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Inbar Nardi-AgmonDepartment of Medicine, Division of Cardiology, Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Ashley Di MeoDivision of Clinical Biochemistry, Laboratory Medicine Program, Toronto General Hospital, Toronto, Canada.
Leo LamDepartment of Pathology and Laboratory Medicine (LabPlus), Grafton, Auckland, New Zealand.
Campbell KyleDepartment of Pathology and Laboratory Medicine (LabPlus), Grafton, Auckland, New Zealand.
Husam Abdel-QadirDepartment of Medicine, Division of Cardiology, Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Eitan AmirDepartment of Medicine, Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Paaladinesh ThavendiranathanDepartment of Medicine, Division of Cardiology, Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cardiac biomarkerscardio-oncologymacrotroponintroponin antibody

Identifiers

PMID39239330
PMCPMC11372023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.